Concurrent macrolide and statin – a common interaction

Abstract

In this series we present a number of prescribing safety indicators developed as part of an RCGP project. 1 The evidence base behind each of the indicators is given along with information to illustrate their clinical significance. We provide a ‘real‐life’ audit based on the indicator to show how practices could begin to analyse their own prescribing data. Copyright © 2011 Wiley Interface Ltd